These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 18763309)
21. Extension of the in vivo half-life of endostatin and its improved anti-tumor activities upon fusion to a humanized antibody against tumor-associated glycoprotein 72 in a mouse model of human colorectal carcinoma. Lee SH; Jeung IC; Park TW; Lee K; Lee DG; Cho YL; Lee TS; Na HJ; Park YJ; Lee HG; Jeong MS; Bae KH; Lee SC; Lee HJ; Kwon YG; Hong HJ; Kim JS; Min JK Oncotarget; 2015 Mar; 6(9):7182-94. PubMed ID: 25762629 [TBL] [Abstract][Full Text] [Related]
22. Suppression of tumor growth and metastasis by simultaneously blocking vascular endothelial growth factor (VEGF)-A and VEGF-C with a receptor-immunoglobulin fusion protein. Zhang D; Li B; Shi J; Zhao L; Zhang X; Wang C; Hou S; Qian W; Kou G; Wang H; Guo Y Cancer Res; 2010 Mar; 70(6):2495-503. PubMed ID: 20197464 [TBL] [Abstract][Full Text] [Related]
24. Anti-VEGF antibody therapy induces tumor hypoxia and stanniocalcin 2 expression and potentiates growth of human colon cancer xenografts. Miyazaki S; Kikuchi H; Iino I; Uehara T; Setoguchi T; Fujita T; Hiramatsu Y; Ohta M; Kamiya K; Kitagawa K; Kitagawa M; Baba S; Konno H Int J Cancer; 2014 Jul; 135(2):295-307. PubMed ID: 24375080 [TBL] [Abstract][Full Text] [Related]
25. [Prokaryotic expression, purification and antigenicity identification of mouse VEGFR2 extracellular 1-4 IgG-like domains]. Wang W; Yin X; Li Y; Tian R; Yan J; Gao J; Yu J Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jan; 33(1):13-7. PubMed ID: 23353147 [TBL] [Abstract][Full Text] [Related]
26. Functional role of Egr-1 mediating VEGF-induced tissue factor expression in the retinal capillary endothelium. Sassa Y; Hata Y; Murata T; Yamanaka I; Honda M; Hisatomi T; Fujisawa K; Sakamoto T; Kubota T; Nakagawa K; Sueishi K; Ishibashi T Graefes Arch Clin Exp Ophthalmol; 2002 Dec; 240(12):1003-10. PubMed ID: 12483323 [TBL] [Abstract][Full Text] [Related]
27. Antitumor effects of FP3 in combination with capecitabine on PDTT xenograft models of primary colon carcinoma and related lymphatic and hepatic metastases. Jin K; Lan H; Xie B; He K; Xu Z; Li G; Han N; Teng L; Cao F Cancer Biol Ther; 2012 Jul; 13(9):737-44. PubMed ID: 22617773 [TBL] [Abstract][Full Text] [Related]
28. Vascular endothelial growth factor-C secreted by pancreatic cancer cell line promotes lymphatic endothelial cell migration in an in vitro model of tumor lymphangiogenesis. Ochi N; Matsuo Y; Sawai H; Yasuda A; Takahashi H; Sato M; Funahashi H; Okada Y; Manabe T Pancreas; 2007 May; 34(4):444-51. PubMed ID: 17446844 [TBL] [Abstract][Full Text] [Related]
29. Tissue factor-dependent vascular endothelial growth factor production by human fibroblasts in response to activated factor VII. Ollivier V; Bentolila S; Chabbat J; Hakim J; de Prost D Blood; 1998 Apr; 91(8):2698-703. PubMed ID: 9531578 [TBL] [Abstract][Full Text] [Related]
30. Improved free vascular graft survival in an irradiated surgical site following topical application of rVEGF. Schultze-Mosgau S; Wehrhan F; Rödel F; Amann K; Radespiel-Tröger M; Grabenbauer GG Int J Radiat Oncol Biol Phys; 2003 Nov; 57(3):803-12. PubMed ID: 14529787 [TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor and enhanced angiogenesis do not promote metastatic conversion of a newly established azoxymethane-induced colon cancer cell line. Belinsky GS; Claffey KP; Nambiar PR; Guda K; Rosenberg DW Mol Carcinog; 2005 Jun; 43(2):65-74. PubMed ID: 15768385 [TBL] [Abstract][Full Text] [Related]
32. Granulocyte-Colony Stimulating Factor Receptor, Tissue Factor, and VEGF-R Bound VEGF in Human Breast Cancer In Loco. Wojtukiewicz MZ; Sierko E; Skalij P; Kamińska M; Zimnoch L; Brekken RA; Thorpe PE Adv Clin Exp Med; 2016; 25(3):505-11. PubMed ID: 27629739 [TBL] [Abstract][Full Text] [Related]
33. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature. Huang X; Molema G; King S; Watkins L; Edgington TS; Thorpe PE Science; 1997 Jan; 275(5299):547-50. PubMed ID: 8999802 [TBL] [Abstract][Full Text] [Related]
34. Regulation of vascular endothelial growth factor (VEGF) production and angiogenesis by tissue Factor (TF) in SGC-7901 gastric cancer cells. Zhang J; Ding J; Zhang X; Shao X; Hao Z Cancer Biol Ther; 2005 Jul; 4(7):769-72. PubMed ID: 15846107 [TBL] [Abstract][Full Text] [Related]
35. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. Warren RS; Yuan H; Matli MR; Gillett NA; Ferrara N J Clin Invest; 1995 Apr; 95(4):1789-97. PubMed ID: 7535799 [TBL] [Abstract][Full Text] [Related]
36. Antitumor effect and mechanism of action of a tumor-targeting recombinant human tumor necrosis factor-α fusion protein mediated by urokinase. Dai YC; Yang SM; Wang X; Zhou YJ; Hou G; Huang DN Mol Med Rep; 2015 Jun; 11(6):4333-40. PubMed ID: 25672264 [TBL] [Abstract][Full Text] [Related]
37. Fusion protein tTF-EG3287 induces occlusion of tumor vessels and impairs tumor growth in human colon caner. Qiu GQ; Xie X; Zhao B; Xu LZ; Chen YQ Neoplasma; 2019 Mar; 66(2):252-260. PubMed ID: 30569722 [TBL] [Abstract][Full Text] [Related]
38. Recombinant vascular endothelial growth factor secreted from tissue-engineered bioartificial muscles promotes localized angiogenesis. Lu Y; Shansky J; Del Tatto M; Ferland P; Wang X; Vandenburgh H Circulation; 2001 Jul; 104(5):594-9. PubMed ID: 11479259 [TBL] [Abstract][Full Text] [Related]
39. Inhibiting the growth of malignant melanoma by blocking the expression of vascular endothelial growth factor using an RNA interference approach. Tao J; Tu YT; Huang CZ; Feng AP; Wu Q; Lian YJ; Zhang LX; Zhang XP; Shen GX Br J Dermatol; 2005 Oct; 153(4):715-24. PubMed ID: 16181451 [TBL] [Abstract][Full Text] [Related]
40. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression. Takano S; Tsuboi K; Tomono Y; Mitsui Y; Nose T Br J Cancer; 2000 Jun; 82(12):1967-73. PubMed ID: 10864205 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]